Search Result

Results for "

FABP5

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Cannabinoid Receptor (1) FABP (9) NF-κB (1) PKC (1) PPAR (1) Reference Standards (2) Small Interfering RNA (siRNA) (3)
By Research Areas:	Cardiovascular Disease (5) Inflammation/Immunology (2) Metabolic Disease (8) Neurological Disease (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Natural
Products

Recombinant Proteins

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-145990

FABPs ligand 6 1 Publications Verification MF6	FABP	Inflammation/Immunology
FABPs ligand 6 (MF6) is an *FABP5* and *FABP7* inhibitor with K_D values of 874 nM and 20 nM, respectively. FABPs ligand 6 can be used for multiple sclerosis research .

HY-161702

RO6806051	FABP	Metabolic Disease
RO6806051 (compound12) is a potent dual fatty acid binding protein 4 and 5 (FABP4 and FABP5) inhibitor with good selectivity and absorption, distribution, metabolism and excretion (eADME) properties .

HY-160457

FABP4/5-IN-5	FABP	Metabolic Disease
FABP4/5-IN-5 (compound D9) is a potent inhibitor of *FABP4 and FABP*5,? with the IC₅₀s of 4.68 μM and 10.72 μM, respectively.FABP4/5-IN-5 plays an important role in metabolism disorder like diabetes mellitus .

HY-101903A

BMS-309403 sodium Maximum Cited Publications 15 Publications Verification	FABP	Cardiovascular Disease Metabolic Disease
BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with K_is of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .

HY-101903

BMS-309403 Maximum Cited Publications 15 Publications Verification	FABP	Cardiovascular Disease Metabolic Disease
BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with K_is of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .

HY-RS04661

FABP5 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
FABP5 Human Pre-designed siRNA Set A contains three designed siRNAs for FABP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FABP5 Human Pre-designed siRNA Set A FABP5 Human Pre-designed siRNA Set A

HY-RS23039

Fabp5 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Fabp5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Fabp5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fabp5 Rat Pre-designed siRNA Set A Fabp5 Rat Pre-designed siRNA Set A

HY-RS16605

Fabp5 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Fabp5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Fabp5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fabp5 Mouse Pre-designed siRNA Set A Fabp5 Mouse Pre-designed siRNA Set A

HY-159115

ART26.12	FABP Cannabinoid Receptor PPAR NF-κB PKC	Neurological Disease Metabolic Disease Inflammation/Immunology
ART26.12 is a potent, selective and orally active inhibitor of *FABP5. ART26.12 can regulate lipid metabolism and activate cannabinoid receptors*. ART26.12 has analgesic effects and can be used in the research of diseases such as peripheral neuropathy and psoriasis .

HY-160456

FABP4/5-IN-4	FABP	Metabolic Disease
FABP4/5-IN-4 (compound E1) is a potent inhibitor of *FABP4 and FABP5, with the IC₅₀s of 3.78 μM and 5.72 μM, respectively. FABP*4/5-IN-4 plays an important role in metabolism disorder like diabetes mellitus .

HY-101903AR

BMS-309403 sodium (Standard)	Reference Standards FABP	Cardiovascular Disease Metabolic Disease
BMS-309403 (sodium) (Standard) is the analytical standard of BMS-309403 (sodium). This product is intended for research and analytical applications. BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .

HY-101903R

BMS-309403 (Standard)	Reference Standards FABP	Cardiovascular Disease Metabolic Disease
BMS-309403 (Standard) is the analytical standard of BMS-309403. This product is intended for research and analytical applications. BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .

HY-N8144

Niga-ichigoside F1	Others	Cardiovascular Disease
Niga-ichigoside F1, an orally active ursane triterpenoid, has antihyperlipidemic and antioxidant activities. Niga-ichigoside F1 can prevent high-fat diet (HFD)-induced hepatic steatosis .

Niga-ichigoside F1	Cardiovascular Disease Rhynchosia volubilis Lour. Triterpenes Classification of Application Fields Terpenoids Labiatae Source classification Plants Disease Research Fields	Others
Niga-ichigoside F1, an orally active ursane triterpenoid, has antihyperlipidemic and antioxidant activities. Niga-ichigoside F1 can prevent high-fat diet (HFD)-induced hepatic steatosis .

Species:	Human (2) Mouse (1)
Tag:	His (2) Tag Free (1)
Source:	E. coli (3)

Cat. No.	Compare	Product Name	Species	Source

HY-P75214

	FABP5 Protein, Human Fatty acid-binding protein 5; E-FABP; PA-FABP; FABP5	Human	E. coli
	FABP5 acts as an intracellular carrier of long-chain fatty acids and related lipids and regulates ligand metabolism. It selectively delivers specific fatty acids from the cytoplasm to the nucleus, activating nuclear receptors including peroxisome proliferator-activated receptor delta, promoting proliferation and survival. FABP5 Protein, Human is the recombinant human-derived FABP5 protein, expressed by E. coli , with tag free.

HY-P72660

	FABP5 Protein, Human (His) Fatty acid-binding protein 5; E-FABP; PA-FABP; FABP5	Human	E. coli
	FABP5 acts as an intracellular carrier of long-chain fatty acids and related lipids and regulates ligand metabolism. It selectively delivers specific fatty acids from the cytoplasm to the nucleus, activating nuclear receptors including peroxisome proliferator-activated receptor delta, promoting proliferation and survival. FABP5 Protein, Human (His) is the recombinant human-derived FABP5 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P79398

	FABP5 Protein, Mouse (His) Fatty acid-binding protein 5; FABP5; Epidermal-type fatty acid-binding protein; E-FABP; Fatty acid-binding protein, epidermal; Keratinocyte lipid-binding protein; Psoriasis-associated fatty acid-binding protein homolog; PA-FABP; FABPe; Klbp; Mal1	Mouse	E. coli
	FABP5, also known as E-FABP, acts as an intracellular carrier of long-chain fatty acids and related lipids and regulates ligand metabolism.In addition to cytoplasmic transport, it selectively transports fatty acids to the nucleus, activates nuclear receptors, and delivers retinoic acid to promote proliferation.FABP5 Protein, Mouse (His) is the recombinant mouse-derived FABP5 protein, expressed by E.coli , with N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

FABP5 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
FABP5 Human Pre-designed siRNA Set A contains three designed siRNAs for FABP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fabp5 Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Fabp5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Fabp5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fabp5 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Fabp5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Fabp5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks